AL
Alma Yesodot Ltd.
KVSR | TA
Overview
Corporate Details
- ISIN(s):
- IL0011731457
- LEI:
- Country:
- Israel
- Address:
- HaBarzel 3, 6971005 Tel Aviv - Jaffa
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Kvasir focuses on developing innovative medical devices and diagnostic technologies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-24 17:08 |
Regulatory News Service
Opening of Trading on April 27 2025-ALMA YESODOT B1
|
Hebrew (modern) | 118.8 KB | |
| 2025-04-23 11:59 |
Regulatory News Service
Identifying Details of New Security-ALMA YESODOT B1
|
Hebrew (modern) | 87.5 KB | |
| 2024-11-05 15:46 |
Regulatory News Service
Changes in the company's name and security, effective as of November 7, 2024
|
Hebrew (modern) | 108.5 KB | |
| 2024-10-29 18:37 |
Regulatory News Service
The sector classification of the company will be changed, as of October 31, 202…
|
Hebrew (modern) | 121.3 KB | |
| 2024-10-29 17:20 |
Regulatory News Service
Base price of 1 agora and unlimited price fluctuation
|
Hebrew (modern) | 90.8 KB | |
| 2023-05-22 23:20 |
Regulatory News Service
Frost and Sullivan is terminating coverage , following the completion of its co…
|
Hebrew (modern) | 174.5 KB | |
| 2023-05-22 23:20 |
Share Issue/Capital Change
Frost and Sullivan is terminating coverage , following the completion of its co…
|
Russian | 46.0 KB | |
| 2023-03-23 21:00 |
Business and Financial Review
Analysis update following financial report- price target is updated to NIS 22.7
|
English | 1.2 MB | |
| 2023-03-23 21:00 |
Major Shareholding Notification
Analysis update following financial report- price target is updated to NIS 22.7
|
Russian | 71.0 KB | |
| 2022-12-11 20:40 |
Regulatory News Service
Analysis update following financial report- price target is updated to NIS 32.9…
|
English | 1.2 MB | |
| 2022-12-11 20:40 |
Share Issue/Capital Change
Analysis update following financial report- price target is updated to NIS 32.9…
|
Russian | 67.3 KB | |
| 2022-08-30 20:47 |
Business and Financial Review
Analysis update report ,target price is at 47.6NIS
|
English | 1.2 MB | |
| 2022-08-30 20:47 |
Regulatory News Service
Analysis update report ,target price is at 47.6NIS
|
Russian | 63.9 KB | |
| 2022-08-18 16:58 |
Company Presentation
Presentation
|
English | 3.0 MB | |
| 2022-08-18 16:58 |
Report Publication Announcement
Presentation
|
Russian | 42.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
|
Antibiotice S.A. | Romania | ATB | |
|
Aran Research & Development (1982) Ltd. | Israel | ARAN | |
|
Asarina Pharma AB | Sweden | ASAP | |
|
AstraZeneca PLC | United Kingdom | AZN |